Mild Cognitive Impairment Clinical Trial
— FallsPACTOfficial title:
Falls Prevention Through Physical And Cognitive Training (Falls PACT) in Older Adults With Mild Cognitive Impairment: A Randomised Controlled Trial
Verified date | May 2017 |
Source | The Hong Kong Polytechnic University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This randomised controlled trial aims to determine the effectiveness of combined physical and cognitive training in preventing falls and decreasing risks of falls among community-dwelling older persons with mild cognitive impairment (MCI).
Status | Active, not recruiting |
Enrollment | 95 |
Est. completion date | August 31, 2018 |
Est. primary completion date | January 31, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 60 Years and older |
Eligibility |
Inclusion Criteria: - 60 years or above - community-dwelling in Manila, Philippines - diagnosed with MCI Exclusion Criteria: - diagnosis of dementia or Alzheimer's disease - history of major medical conditions such as cerebrovascular disease, cardiopulmonary condition, serious musculoskeletal disease, cancer, major psychiatric condition - have severe visual and/or hearing impairment - taking medications such sedatives, antidepressants, diuretics, anti-epilepsy. |
Country | Name | City | State |
---|---|---|---|
Philippines | University of Santo Tomas | Manila | Metro Manila |
Lead Sponsor | Collaborator |
---|---|
The Hong Kong Polytechnic University | University of Santo Tomas |
Philippines,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Change in Fear of Falling | Falls Efficacy Scale - International | Baseline, 3 months, 9 months | |
Other | Change in Quality of Life | European Quality of life - five dimensions - five levels (EQ-5D-5L) questionnaire | Baseline, 3 months, 9 months | |
Primary | Falls Rate | Number of Falls over a period of time | 9 months | |
Secondary | Change in Physiologic Profile Assessment (PPA) score | Physiologic risk for falls | Baseline, 3 months, 9 months | |
Secondary | Change in Falls Risks for Older People in the Community (FROP-Com) Screen score | Overall fall risk | Baseline, 3 months, 9 months | |
Secondary | Change in Global Cognitive Function | Montreal Cognitive Assessment (MoCA) | Baseline, 3 months, 9 months | |
Secondary | Change in Memory Function | Memory Index Score of the Montreal Cognitive Assessment (MoCA-MIS) | Baseline, 3 months, 9 months | |
Secondary | Change in Executive Function | Executive Function Performance Test (EFPT) | Baseline, 3 months, 9 months | |
Secondary | Change in Balance | Time Up and Go Test (TUGT) | Baseline, 3 months, 9 months | |
Secondary | Change in Gait Speed | 10-Meter Walk Test (10MWT) | Baseline, 3 months, 9 months | |
Secondary | Change in Muscle Strength | 30s-Chair-Stand Test (CST) | Baseline, 3 months, 9 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04513106 -
Promoting Advance Care Planning for Persons With Early-stage Dementia in the Community: a Feasibility Trial
|
N/A | |
Recruiting |
NCT06011681 -
The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
|
||
Recruiting |
NCT04522739 -
Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease
|
Phase 4 | |
Active, not recruiting |
NCT03676881 -
Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
|
||
Not yet recruiting |
NCT05041790 -
A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment
|
Phase 4 | |
Recruiting |
NCT04121156 -
High Definition Transcranial Direct Current Stimulation (HD-tDCS) in Patients With Mild Cognitive Impairment
|
N/A | |
Recruiting |
NCT03605381 -
MORbidity PRevalence Estimate In StrokE
|
||
Completed |
NCT02774083 -
Cognitive Training Using Feuerstein Instrumental Enrichment
|
N/A | |
Completed |
NCT01315639 -
New Biomarker for Alzheimer's Disease Diagnostic
|
N/A | |
Enrolling by invitation |
NCT06023446 -
Can (Optical Coherence Tomography) Pictures of the Retina Detect Alzheimer's Disease at Its Earliest Stages?
|
||
Completed |
NCT04567745 -
Automated Retinal Image Analysis System (EyeQuant) for Computation of Vascular Biomarkers
|
Phase 1 | |
Recruiting |
NCT05579236 -
Cortical Disarray Measurement in Mild Cognitive Impairment and Alzheimer's Disease
|
||
Completed |
NCT03583879 -
Using Gait Robotics to Improve Symptoms of Parkinson's Disease
|
N/A | |
Terminated |
NCT02503501 -
Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease
|
Phase 2 | |
Not yet recruiting |
NCT03740178 -
Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005)
|
Phase 1 | |
Active, not recruiting |
NCT05204940 -
Longitudinal Observational Biomarker Study
|
||
Recruiting |
NCT02663531 -
Retinal Neuro-vascular Coupling in Patients With Neurodegenerative Disease
|
N/A | |
Recruiting |
NCT06150352 -
Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
|
||
Recruiting |
NCT03507192 -
Effects of Muscle Relaxation on Cognitive Function in Patients With Mild Cognitive Impairment and Early Stage Dementia.
|
N/A | |
Completed |
NCT04817176 -
MI-CBT Adherence Program for Lifestyle Interventions in Older Adults
|
Early Phase 1 |